U.S. House Democrats Ask GAO To Probe U.S. Government Role In Developing Coronavirus Treatment Remdesivir

Bloomberg Law: Democrats Seek GAO Probe of Gilead’s Covid Treatment Remdesivir
“U.S. House Oversight Committee Chair Carolyn Maloney and Sen. Debbie Stabenow ask the Government Accountability Office to investigate the discovery and development of Gilead’s remdesivir…” (Chipman, 7/28).

STAT: Lawmakers urge congressional watchdog to probe U.S. government’s role in discovering remdesivir
“…In a letter to the congressional watchdog, the lawmakers argue that the medicine, which is sold by Gilead Sciences, eventually reached patients thanks, in part, to an estimated $70 million in federal funding and ‘key scientific contributions’ from U.S. government scientists…” (Silverman, 7/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.